Sudarshan Pharma Industries has informed that the exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 14, 2026 for Vasantrai Ratilal Mehta, Jatin Vasantrai Mehta, Hemal V Mehta HUF, Mrs. Devangi Hemal Mehta, Sachin V Mehta HUF and Mrs. Namrata Sachin Mehta
The above information is a part of company’s filings submitted to BSE.